Mark Gelfand,Howard Levin,Charles Lennox,Marat Fudim,Zoar Jacob Engelman,Martin M. Grasse,Mark S. Leung,Brett Schleicher
申请号：
US13869765
公开号：
US20130310823A1
申请日:
2013.04.24
申请国别(地区):
US
年份:
2013
代理人:
摘要：
Systems, devices, and methods for treating a patient having a sympathetically mediated disease associated at least in part with augmented peripheral chemoreflex or heightened sympathetic activation. The treatments include ablating one or more peripheral chemoreceptors or associated afferent nerves to reduce or remove afferent neural signals from the peripheral chemoreceptor.
